Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Trinity Biotech ( (TRIB) ) just unveiled an announcement.
On February 11, 2026, Trinity Biotech received a notice from Nasdaq that its American Depositary Shares had failed for 30 consecutive business days to meet the exchange’s minimum bid price requirement of $1.00 per share. The ADSs will continue trading on the Nasdaq Global Select Market under the symbol TRIB while the company works to restore compliance.
Under Nasdaq rules, Trinity Biotech has 180 calendar days, until August 10, 2026, for its ADSs to close at or above $1.00 for at least ten consecutive business days to regain compliance. Management is monitoring the share price and evaluating options to cure the deficiency, and if it falls short, the company may seek an additional compliance period by meeting other listing standards, a process that could influence investor confidence and the company’s capital markets access.
The most recent analyst rating on (TRIB) stock is a Hold with a $0.80 price target. To see the full list of analyst forecasts on Trinity Biotech stock, see the TRIB Stock Forecast page.
Spark’s Take on TRIB Stock
According to Spark, TipRanks’ AI Analyst, TRIB is a Neutral.
Overall score is held down primarily by weak financial performance (sharp TTM revenue decline, deep losses, negative equity, and negative free cash flow). Technicals are only mildly supportive with mixed trend signals, and valuation provides limited support due to a negative P/E and no dividend yield data.
To see Spark’s full report on TRIB stock, click here.
More about Trinity Biotech
Trinity Biotech plc is a commercial-stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. It develops, acquires, manufactures and markets diagnostic systems for point-of-care and clinical laboratory markets, selling in the U.S. and via distributors and partners in more than 75 countries worldwide.
Average Trading Volume: 3,298,951
Technical Sentiment Signal: Strong Sell
Current Market Cap: $15.33M
For an in-depth examination of TRIB stock, go to TipRanks’ Overview page.